Concepedia

Tanmoy Ganguly

TG

21

Publications

1.4K

Citations

16

H-Index

1991

Active since

Affiliations

Momenta Pharmaceuticals (United States)(Current)

University of Kentucky

Bhabha Atomic Research Centre

Albert B. Chandler Hospital

Massachusetts Institute of Technology

Tanmoy Ganguly is an author at Momenta Pharmaceuticals (United States) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1991–2022

21

Publications

21

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 613 citations · Full text

M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis

He Zhou, Sucharita Roy, Edward Cochran et al. · PLoS ONE · 2011 · 176 citations · Full text

, , +19

Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5.

Tanmoy Ganguly, Miechelle L. O’Brien, Saul J. Karpen et al. · Journal of Clinical Investigation · 1997 · 104 citations · Full text

, , +23

A global benchmark study using affinity-based biosensors

Rebecca L. Rich, Giuseppe A. Papalia, Peter J. Flynn et al. · Analytical Biochemistry · 2008 · 97 citations · Full text

, , +4

Inhibition of cellular immune responses by in experimental models

Tanmoy Ganguly · Phytomedicine · 2001 · 68 citations

, , +7

Rows per page

1–5 of 21